{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:54:34Z","timestamp":1794322474171,"version":"4.9.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clinthera.2024.11.017","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T12:15:57Z","timestamp":1734351357000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thrombotic Microangiopathy Associated with Calcineurin Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data"],"prefix":"10.1016","volume":"47","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoling","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.11.017_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2017.12.017","article-title":"Tacrolimus: an updated review on delivering strategies for multifarious diseases","volume":"114","author":"Dheer","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0002","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.3389\/ti.2023.11012","article-title":"Solid organ donation and transplantation in the United Kingdom: good governance is key to success","volume":"36","author":"Johnston-Webber","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0003","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00262.2020","article-title":"Calcineurin inhibitors: a double-edged sword","volume":"320","author":"Ume","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5414\/CN107036","article-title":"Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy","volume":"77","author":"Carson","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0005","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/ajkd.2000.17690","article-title":"Cyclosporine and tacrolimus-associated thrombotic microangiopathy","volume":"36","author":"Pham","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0006","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imj.12048","article-title":"Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients","volume":"43","author":"Nwaba","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","article-title":"FK506-associated thrombotic microangiopathy: report of two cases and review of the literature","volume":"67","author":"Trimarchi","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0009","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"issue":"Suppl 23","key":"10.1016\/j.clinthera.2024.11.017_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-0012.2011.01454.x","article-title":"A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation","volume":"25","author":"Miura","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0011","article-title":"Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient","volume":"2013","author":"Boyer","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0012","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00467-014-3036-8","article-title":"De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus","volume":"30","author":"Cortina","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jca.21673","article-title":"Thrombotic thrombocytopenic purpura: a 5-year tertiary care centre experience","volume":"34","author":"Swart","year":"2019","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0016","first-page":"3119","article-title":"FK506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS)","volume":"23","author":"Lieberman","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0017","first-page":"3133","article-title":"FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro","volume":"23","author":"Moutabarik","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0013","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13023-022-02409-3","article-title":"Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing","volume":"17","author":"Merlen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0018","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.transproceed.2019.05.002","article-title":"An atypical presentation of thrombotic microangiopathy after lung transplant: a case report","volume":"51","author":"Menezes","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0019","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.transproceed.2016.04.005","article-title":"Belatacept and eculizumab for treatment of calcineurin inhibitor-induced thrombotic microangiopathy after kidney transplantation: case report","volume":"48","author":"Merola","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0020","article-title":"A case report of quinine-induced thrombotic microangiopathy successfully treated with eculizumab","volume":"12","author":"Ng","year":"2024","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5414\/CN108163","article-title":"Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: a case report","volume":"83","author":"Safa","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0022","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.19026","article-title":"A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies","volume":"203","author":"Scully","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0023","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1054\/mehy.2000.1173","article-title":"Cyclosporine therapeutic and toxic effects may be related to different cyclosporine concentration zones in plasma","volume":"56","author":"Wu","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.clinthera.2024.11.017_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10157-008-0037-6","article-title":"Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus","volume":"12","author":"Saito","year":"2008","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:48:09Z","timestamp":1738766889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0149291824003655"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.11.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Microangiopathy Associated with Calcineurin Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}